Genetic, ethnic, and gender differences in the pharmacokinetics of antiretroviral agents.
about
Interindividual variability in pharmacokinetics of generic nucleoside reverse transcriptase inhibitors in TB/HIV-coinfected Ghanaian patients: UGT2B7*1c is associated with faster zidovudine clearance and glucuronidationGender difference in 2-year mortality and immunological response to ART in an HIV-infected Chinese population, 2006-2008Pharmacogenetic-based efavirenz dose modification: suggestions for an African population and the different CYP2B6 genotypesSex differences in atazanavir pharmacokinetics and associations with time to clinical events: AIDS Clinical Trials Group Study A5202.Polymorphic variants of cytochrome P450 2B6 (CYP2B6.4-CYP2B6.9) exhibit altered rates of metabolism for bupropion and efavirenz: a charge-reversal mutation in the K139E variant (CYP2B6.8) impairs formation of a functional cytochrome p450-reductase cPopulation pharmacokinetic/pharmacogenetic model for optimization of efavirenz therapy in Caucasian HIV-infected patients.Population pharmacokinetic analysis and pharmacogenetics of raltegravir in HIV-positive and healthy individualsDialogues on diversifying clinical trials: successful strategies for engaging women and minorities in clinical trials.Superior Effects of Antiretroviral Treatment among Men Who have Sex with Men Compared to Other HIV At-Risk Populations in a Large Cohort Study in Hunan, ChinaADME pathway approach for pharmacogenetic studies of anti-HIV therapy.Polymorphic CYP2B6: molecular mechanisms and emerging clinical significance.Body weight cutoff for daily dosage of efavirenz and 60-week efficacy of efavirenz-based regimen in human immunodeficiency virus and tuberculosis coinfected patients receiving rifampin.CYP2B6 genotype-based efavirenz dose recommendations during rifampicin-based antituberculosis cotreatment for a sub-Saharan Africa population.Efavirenz and Metabolites in Cerebrospinal Fluid: Relationship with CYP2B6 c.516G→T Genotype and Perturbed Blood-Brain Barrier Due to Tuberculous Meningitis.Long-Term Effect of Rifampicin-Based Anti-TB Regimen Coadministration on the Pharmacokinetic Parameters of Efavirenz and 8-Hydroxy-Efavirenz in Ethiopian Patients.Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Relationships of Etravirine in HIV-1-Infected, Treatment-Experienced Children and Adolescents in PIANO.Pharmacogenetics-based population pharmacokinetic analysis of efavirenz in HIV-1-infected individuals.
P2860
Q24648578-14A91818-D463-4951-89E4-2AF6A32D011AQ28741389-F8F4AA0C-4968-4696-A97A-6B6E22808455Q31150044-76A203F2-A728-4366-8FCB-9502F130F059Q34495619-28EFFE05-6A84-43FF-BD13-33AE4BDBE764Q35188159-6FA4C8D2-80FB-4D57-87C3-34316E5CD919Q35364120-7D8874B9-A44F-419E-B14D-E0BC3802BAD6Q36018556-5607F2AF-FF98-4456-8B40-8E9F1EF100A2Q36204611-F0CC737A-2BE8-425C-89F5-780D87B8087EQ36732366-71621E6E-24A2-433F-8D5A-9571ABB10E73Q36845126-842621E6-5901-4063-91E3-28778D7711A9Q36885659-07C4350A-7E47-4DD0-90B9-4B6B9C83BDAEQ37392789-06E8626B-530C-4913-954C-CD70E65A28F6Q38855121-13DACF31-9184-4A7F-BC95-7EC9B0EDAC93Q39304616-9E713D13-F8A4-4D84-9903-7EF647A00007Q40694902-EDE02DC5-6A1F-43B9-B046-3E761BA4D94BQ40722214-09C4765C-9D6B-4CBA-B5D1-7C96739D8DC1Q46118142-88D506C9-AC0E-4179-92A0-AFAC74397FC8
P2860
Genetic, ethnic, and gender differences in the pharmacokinetics of antiretroviral agents.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Genetic, ethnic, and gender differences in the pharmacokinetics of antiretroviral agents.
@ast
Genetic, ethnic, and gender differences in the pharmacokinetics of antiretroviral agents.
@en
type
label
Genetic, ethnic, and gender differences in the pharmacokinetics of antiretroviral agents.
@ast
Genetic, ethnic, and gender differences in the pharmacokinetics of antiretroviral agents.
@en
prefLabel
Genetic, ethnic, and gender differences in the pharmacokinetics of antiretroviral agents.
@ast
Genetic, ethnic, and gender differences in the pharmacokinetics of antiretroviral agents.
@en
P356
P1476
Genetic, ethnic, and gender differences in the pharmacokinetics of antiretroviral agents.
@en
P2093
Amalio Telenti
Margalida Rotger
P2860
P2888
P304
P356
10.1007/BF02696655
P577
2006-09-01T00:00:00Z